[Benchmarking China's Top-Tier Medical Institutions Against Global Standards: A Quantitative Analysis of the Gap Using Internationally Recognized Metrics].
Gui Yang, Yajuan Cui, Rui Dai, Qiuqiu Zhang, Wenqi Luo
{"title":"[Benchmarking China's Top-Tier Medical Institutions Against Global Standards: A Quantitative Analysis of the Gap Using Internationally Recognized Metrics].","authors":"Gui Yang, Yajuan Cui, Rui Dai, Qiuqiu Zhang, Wenqi Luo","doi":"10.12182/20250160302","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the gap between China's top-tier medical institutions and top-tier international medical institutions, and to provide references for the construction of first-class medical science discipline in China.</p><p><strong>Methods: </strong>Using globally recognized rankings of medical institutions, we selected 24 top-tier international medical institutions and 11 top-tier Chinese medical institutions. Publicly available, general, and comparable data on indicators were collected to analyze the performance and gaps between top-tier international and Chinese medical institutions in human resources development, talent cultivation, scientific research, social services, and discipline construction.</p><p><strong>Results: </strong>In the field of medicine, the largest gap between top-tier international and Chinese medical institutions was in high-level talent. Specifically, the average numbers of individuals who are Clarivate Analytics' Highly Cited Researchers, who are Nobel Prize laureates in Physiology or Medicine, and who serve on advisory boards or editorial boards of top medical journals, and who rank among the Top 2 000 Medicine Scientists were 1.00, 0.09, 0.45 and 4.00, respectively, among top-tier Chinese medical institutions, while those of the top-tier international medical institutions were 131.46, 118.25, 9.72, and 6.76 times, respectively, those of the Chinese medical institutions. The second largest gap was in social services and medical innovation. The average proportion of industrial collaboration papers and the number of clinical trials of China's top-tier medical institutions were 1.51% and 1 851, respectively, while those of international top-tier medical institutions were 3.62 and 1.87, times, respectively, those of top-tier Chinese medical institutions. However, the average number of (untranslated) patents held by top-tier international medical institutions was only 15% of that of China's top-tier medical institutions.The third largest gap was in scientific research. The average number of papers published in New England Journal of Medicine, Journal of the American Medical Association, The Lancet, and British Medical Journal, the percentage of hot papers in papers included in Web of Science, the percentage of highly cited papers, the percentage of international collaboration papers, the total number of citations per paper, category normalized citation impact (CNCI), and the number of publications of top-tier Chinese medical institutions were 78, 0.03%, 1.39%, 22.55%, 19.61, 1.26, 30 706, while those of the top-tier international medical institutions were 6.96, 2.66, 2.57, 2.15, 1.83, 1.58 and 1.54 times those of the Chinese medical institutions, respectively. However the average percentage of zero-citation papers of top-tier international medical institutions was only 71% of that of China's top-tier medical institutions. Furthermore, in discipline development, the average overall scores of the Times Higher Education (THE) and QS rankings for medicine-related disciplines of top-tier Chinese medical institutions were 72.84 and 69.30, respectively, while those of top-tier international medical institutions were 1.38 and 1.21 times those of the Chinese medical institutions. However, in terms of talent cultivation, the average number of students of China's top-tier medical institutions was 10724, which is roughly double that of international institutions.</p><p><strong>Conclusion: </strong>Currently, China's top-tier medical institutions are still in a basic stage that emphasizes the quality of talent cultivation and medical services. There is considerable room for development and potential for catching up in multiple aspects, especially in high-level talent, medical research, and innovation. It is recommended that the construction experience of top-tier international medical institutions should be fully utilized to build China's first-class medical science discipline.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 1","pages":"166-174"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11914021/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"四川大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12182/20250160302","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To evaluate the gap between China's top-tier medical institutions and top-tier international medical institutions, and to provide references for the construction of first-class medical science discipline in China.
Methods: Using globally recognized rankings of medical institutions, we selected 24 top-tier international medical institutions and 11 top-tier Chinese medical institutions. Publicly available, general, and comparable data on indicators were collected to analyze the performance and gaps between top-tier international and Chinese medical institutions in human resources development, talent cultivation, scientific research, social services, and discipline construction.
Results: In the field of medicine, the largest gap between top-tier international and Chinese medical institutions was in high-level talent. Specifically, the average numbers of individuals who are Clarivate Analytics' Highly Cited Researchers, who are Nobel Prize laureates in Physiology or Medicine, and who serve on advisory boards or editorial boards of top medical journals, and who rank among the Top 2 000 Medicine Scientists were 1.00, 0.09, 0.45 and 4.00, respectively, among top-tier Chinese medical institutions, while those of the top-tier international medical institutions were 131.46, 118.25, 9.72, and 6.76 times, respectively, those of the Chinese medical institutions. The second largest gap was in social services and medical innovation. The average proportion of industrial collaboration papers and the number of clinical trials of China's top-tier medical institutions were 1.51% and 1 851, respectively, while those of international top-tier medical institutions were 3.62 and 1.87, times, respectively, those of top-tier Chinese medical institutions. However, the average number of (untranslated) patents held by top-tier international medical institutions was only 15% of that of China's top-tier medical institutions.The third largest gap was in scientific research. The average number of papers published in New England Journal of Medicine, Journal of the American Medical Association, The Lancet, and British Medical Journal, the percentage of hot papers in papers included in Web of Science, the percentage of highly cited papers, the percentage of international collaboration papers, the total number of citations per paper, category normalized citation impact (CNCI), and the number of publications of top-tier Chinese medical institutions were 78, 0.03%, 1.39%, 22.55%, 19.61, 1.26, 30 706, while those of the top-tier international medical institutions were 6.96, 2.66, 2.57, 2.15, 1.83, 1.58 and 1.54 times those of the Chinese medical institutions, respectively. However the average percentage of zero-citation papers of top-tier international medical institutions was only 71% of that of China's top-tier medical institutions. Furthermore, in discipline development, the average overall scores of the Times Higher Education (THE) and QS rankings for medicine-related disciplines of top-tier Chinese medical institutions were 72.84 and 69.30, respectively, while those of top-tier international medical institutions were 1.38 and 1.21 times those of the Chinese medical institutions. However, in terms of talent cultivation, the average number of students of China's top-tier medical institutions was 10724, which is roughly double that of international institutions.
Conclusion: Currently, China's top-tier medical institutions are still in a basic stage that emphasizes the quality of talent cultivation and medical services. There is considerable room for development and potential for catching up in multiple aspects, especially in high-level talent, medical research, and innovation. It is recommended that the construction experience of top-tier international medical institutions should be fully utilized to build China's first-class medical science discipline.
目的:评价中国一流医疗机构与国际一流医疗机构的差距,为中国一流医学学科建设提供参考。方法:采用国际公认的医疗机构排名,选取24家国际顶级医疗机构和11家中国顶级医疗机构。收集公开、通用、可比较的指标数据,分析国际一流医疗机构与中国一流医疗机构在人力资源开发、人才培养、科研、社会服务、学科建设等方面的表现与差距。结果:在医学领域,国际一流医疗机构与中国一流医疗机构差距最大的是高层次人才。其中,中国一流医疗机构高被引研究人员、诺贝尔生理学或医学奖获得者、顶级医学期刊顾问委员会或编委会成员、排名前2000名医学科学家的平均人数分别为1.00、0.09、0.45和4.00人,而国际一流医疗机构的平均人数分别为131.46、118.25、9.72和6.76人。分别是中国医疗机构。第二大差距是社会服务和医疗创新。国内一流医疗机构的产业合作论文和临床试验平均占比分别为1.51%和1851篇,国际一流医疗机构的产业合作论文和临床试验平均占比分别为国内一流医疗机构的3.62倍和1.87倍。然而,国际一流医疗机构的平均(未翻译)专利拥有量仅为中国一流医疗机构的15%。第三大差距是在科学研究方面。中国一线医疗机构在《新英格兰医学杂志》、《美国医学会杂志》、《柳叶刀》、《英国医学杂志》的平均发表论文数、Web of Science收录论文中热点论文占比、高被引论文占比、国际合作论文占比、论文总被引次数、类别标准化引文影响(CNCI)、发表论文数分别为78.0.03%;其中,国际一线医疗机构分别是国内医疗机构的6.96倍、2.66倍、2.57倍、2.15倍、1.83倍、1.58倍和1.54倍。而国际一流医疗机构的平均零引文百分比仅为国内一流医疗机构的71%。在学科发展方面,中国一流医疗机构医学相关学科在泰晤士高等教育(the)和QS排名中的平均综合得分分别为72.84分和69.30分,而国际一流医疗机构的平均综合得分是中国医疗机构的1.38倍和1.21倍。然而,在人才培养方面,中国顶级医疗机构的平均学生人数为10724人,大约是国际机构的两倍。结论:目前,中国的顶级医疗机构仍处于强调人才培养质量和医疗服务质量的基础阶段。中国在很多方面都有很大的发展空间和赶超潜力,特别是在高层次人才、医学研究和创新方面。建议充分利用国际一流医疗机构的建设经验,建设中国一流医学学科。
四川大学学报(医学版)Biochemistry, Genetics and Molecular Biology-Molecular Biology
CiteScore
0.70
自引率
0.00%
发文量
8695
期刊介绍:
"Journal of Sichuan University (Medical Edition)" is a comprehensive medical academic journal sponsored by Sichuan University, a higher education institution directly under the Ministry of Education of the People's Republic of China. It was founded in 1959 and was originally named "Journal of Sichuan Medical College". In 1986, it was renamed "Journal of West China University of Medical Sciences". In 2003, it was renamed "Journal of Sichuan University (Medical Edition)" (bimonthly).
"Journal of Sichuan University (Medical Edition)" is a Chinese core journal and a Chinese authoritative academic journal (RCCSE). It is included in the retrieval systems such as China Science and Technology Papers and Citation Database (CSTPCD), China Science Citation Database (CSCD) (core version), Peking University Library's "Overview of Chinese Core Journals", the U.S. "Index Medica" (IM/Medline), the U.S. "PubMed Central" (PMC), the U.S. "Biological Abstracts" (BA), the U.S. "Chemical Abstracts" (CA), the U.S. EBSCO, the Netherlands "Abstracts and Citation Database" (Scopus), the Japan Science and Technology Agency Database (JST), the Russian "Abstract Magazine", the Chinese Biomedical Literature CD-ROM Database (CBMdisc), the Chinese Biomedical Periodical Literature Database (CMCC), the China Academic Journal Network Full-text Database (CNKI), the Chinese Academic Journal (CD-ROM Edition), and the Wanfang Data-Digital Journal Group.